Ranitidine had a knee-jerk impact on some of the Indian pharma and API companies.
The US FDA found a carcinogenic substance in some samples of acidity medicine Ranitidine.
Ranitidine had a knee-jerk impact on some of the Indian pharma and API companies. The overall ranitidine market for Indian companies is worth nearly Rs 200 crore.Sakshi Batra does a 3-Point Analysis of why this drug is under the lens and what it could mean for pharma and API companies.The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .